Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Metastatic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00039546
What this trial is testing

Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery

Who this might be right for
Breast Cancer
Cancer Research Campaign Clinical Trials Centre
Large-scale testing (Phase 3)Looking for participantsNCT07797218
What this trial is testing

Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBC

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Shanghai Jiao Tong University School of Medicine 220
Testing effectiveness (Phase 2)WithdrawnNCT00313690
What this trial is testing

Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Southern California
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06592625
What this trial is testing

Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer Patients

Who this might be right for
Untreated Early-stage or Locally Advanced Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 60
Not applicableStudy completedNCT04266691
What this trial is testing

Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Zhejiang Cancer Hospital 237
Testing effectiveness (Phase 2)Study completedNCT00004186
What this trial is testing

Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Alabama at Birmingham 55
Not applicableUnknownNCT06288620
What this trial is testing

Microwave Ablation in the Treatment of Early-stage Unifocal Invasive Breast Cancer

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 77
Not applicableUnknownNCT01680523
What this trial is testing

Radical Hysterectomy Followed by Tailored Adjuvant Therapy Versus Primary Chemoradiation Therapy in Bulky Early-stage Cervical Cancer (KGOG 1029)

Who this might be right for
Cervical Cancer
Asan Medical Center 409
Not applicableLooking for participantsNCT06699979
What this trial is testing

Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes

Who this might be right for
Lung Cancer Associated With Cystic AirspacesMultiple Primary Lung CancersNon-Small Cell Lung Cancer
Central South University 300
Very early researchUnknownNCT02207179
What this trial is testing

Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology

Who this might be right for
Breast Cancer
LumaMed 40
Large-scale testing (Phase 3)Looking for participantsNCT06379113
What this trial is testing

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Who this might be right for
Endometrial NeoplasmsAtypical Endometrial HyperplasiaProgesterone Resistance+1 more
Xiaojun Chen 29
Not applicableUnknownNCT04933110
What this trial is testing

Investigation of Hand Functions and Related Parameters in People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Uğur OVACIK 90
Not applicableLooking for participantsNCT05877859
What this trial is testing

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

Who this might be right for
Breast Cancer Triple NegativeBreast Cancer Stage IIBreast Cancer Stage III+1 more
Emory University 10
Testing effectiveness (Phase 2)WithdrawnNCT06654050
What this trial is testing

Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma

Who this might be right for
MesotheliomaMalignant Mesothelioma (MM)Early-stage Mesothelioma+3 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT01423890
What this trial is testing

A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Ontario Clinical Oncology Group (OCOG) 1,011
Testing effectiveness (Phase 2)Ended earlyNCT00776295
What this trial is testing

Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 2
Not applicableNot Yet RecruitingNCT07432802
What this trial is testing

Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)
Aarhus University Hospital 182
Large-scale testing (Phase 3)Study completedNCT02504372
What this trial is testing

Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 1,177
Not applicableStudy completedNCT02481128
What this trial is testing

Surgical Trial to Evaluate the Impact of a Lymphoscintigraphy Prior to Sentinel Node Biopsy in Early Breast Cancer

Who this might be right for
Early-Stage Breast Carcinoma
Kliniken Essen-Mitte 1,198
Not applicableStudy completedNCT06299930
What this trial is testing

Locoregional Recurrence After Neoadjuvant Versus Adjuvant Chemotherapy

Who this might be right for
Breast Cancer
Seoul National University Hospital 10,328
Next Page